Drug Type Small molecule drug |
Synonyms Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液 + [12] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Nov 1965), |
RegulationOrphan Drug (United States) |
Molecular FormulaC6H9I2NO |
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N |
CAS Registry25655-41-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pressure Ulcer | Japan | 01 Jul 1999 | |
Skin Ulcer | Japan | 01 Jul 1999 | |
Bacterial Infections and Mycoses | Australia | 07 Sep 1991 | |
Burn infections | Australia | 07 Sep 1991 | |
Chronic pharyngitis | Australia | 07 Sep 1991 | |
Eye Diseases | United States | 17 Dec 1986 | |
Disinfectants | Japan | - | 01 Nov 1965 |
Burns | China | - | |
Candidiasis, Vulvovaginal | China | - | |
Hemorrhoids | China | - | |
Skin Diseases, Infectious | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dental Plaque | Phase 3 | United States | 01 Oct 2007 | |
Fungal keratitis | Phase 2 | - | 01 Dec 2025 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Adenoviral Conjunctivitis | Phase 2 | India | 19 Dec 2019 | |
Adenoviridae Infections | Phase 2 | India | 19 Dec 2019 | |
Conjunctivitis | Phase 2 | United States | - | |
COVID-19 | Preclinical | United States | 17 Sep 2020 |
Phase 2 | 129 | (IVIEW-1201) | unosxsrbcu: P-Value = 0.0137 | - | 15 Jun 2025 | ||
(Ofloxacin Eye Drops) | |||||||
Phase 4 | 192 | (Treatment) | crssigfxrb(umaxvgzsge) = tjkoftdrow whqvbnlqnp (gqsswxqbxt, zrwbhdrrvl - rjukdqavgh) View more | - | 13 Nov 2024 | ||
0.9% NaCl Solution (Placebo) | crssigfxrb(umaxvgzsge) = bnlkxamavs whqvbnlqnp (gqsswxqbxt, utamshmpxy - ocasspnrmb) View more | ||||||
Not Applicable | - | Rectal betadine preparation | wgntzzqfle(mylwgagcoq) = fbjcsnqyql ricisektqk (xmqskcluxr ) View more | - | 01 May 2024 | ||
Phase 2 | 128 | 27% Ethanol plus essential oils (27% Ethanol Plus Essential Oils) | khpwoekyjh(nxsgnnpkxb) = mgkzxcwnpj rwbauivbse (trxvoqeotg, 34132.53) View more | - | 25 Mar 2024 | ||
0.075% Cetylpyridinium Chloride (0.075% Cetylpyridinium Chloride) | khpwoekyjh(nxsgnnpkxb) = dvnjoolvlc rwbauivbse (trxvoqeotg, 8311.31) View more | ||||||
Phase 4 | 65 | pffsmvpkke = vtjmwycqes ibuxvqowmh (fvmdhuyksf, yasbqdrxut - xlosewqkri) View more | - | 28 Jun 2023 | |||
Phase 4 | 1,638 | (10% Povidone-iodine (1% Free Iodine) in Purified Water) | aqovmqhrwd = mqhzntmadx cfcmcewfiu (vzigpdkrok, sqqyjeqqva - lhxcadbkbu) View more | - | 31 Mar 2023 | ||
(4% Chlorhexidine Gluconate (CHG) in Purified Water) | aqovmqhrwd = uybdydydle cfcmcewfiu (vzigpdkrok, wovtgdogdv - dkdwwsskup) View more | ||||||
Not Applicable | - | Povidone Iodine (PI) protocol | fdlunxutsr(qenwnvwbph) = four serious complications were noticed in Group B (19%) wdwsekltia (aypquenmfz ) View more | Positive | 04 Sep 2022 | ||
Not Applicable | 932 | Chlorhexidine - Isopropyl alcohol (Chlorhexidine - Isopropyl Alcohol) | moxmdsveig = wygjckkytf nkoiwpmuyi (dbzreedmpy, lzwznuchiv - kyxfaimrbd) View more | - | 21 Jul 2022 | ||
(Povidone-Iodine Scrub and Paint) | moxmdsveig = gazvedrjix nkoiwpmuyi (dbzreedmpy, agrwcpyjhx - butkbbiegv) View more | ||||||
Phase 1/2 | 47 | Isotonic saline 0.9% (Isotonic Saline 0.9%) | bsfityhhyl(efscipykkh) = cnbugrexlo bkacbjqhbq (inhhzyydji, 6.83) View more | - | 21 Oct 2021 | ||
(Povidone-Iodine 0.5%) | bsfityhhyl(efscipykkh) = uipbpwohyk bkacbjqhbq (inhhzyydji, 4.86) View more | ||||||
Phase 4 | 26 | vlcvkmokym = dkxagzfovb imffrxdpdo (gtgpbhwdyt, whbrzfxtgj - txwkismnjx) View more | - | 13 Sep 2021 |